Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001828185-25-000059
Filing Date
2025-08-07
Accepted
2025-08-07 08:06:49
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brns-20250630.htm   iXBRL 10-Q 1085380
2 EX-31.1 brns-20250630xexx311.htm EX-31.1 11183
3 EX-31.2 brns-20250630xexx312.htm EX-31.2 11137
4 EX-32.1 brns-20250630xexx321.htm EX-32.1 5561
  Complete submission text file 0001828185-25-000059.txt   5579940

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20250630.xsd EX-101.SCH 45592
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT brns-20250630_cal.xml EX-101.CAL 65020
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20250630_def.xml EX-101.DEF 168665
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20250630_lab.xml EX-101.LAB 542990
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20250630_pre.xml EX-101.PRE 349098
76 EXTRACTED XBRL INSTANCE DOCUMENT brns-20250630_htm.xml XML 635739
Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40367 | Film No.: 251191745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)